Agfa HealthCare reported first-quarter net sales of 324 million euros ($415.2 million U.S.), up 6.2% compared with the 305 million euros ($390.8 million) turned in during the first quarter of 2005.
For the period (end-March 31), the Mortsel, Belgium-based division had earnings before interest and tax of 25 million euros ($32 million), compared with 22.8 million euros ($29.2 million) during the same period a year ago.
Agfa attributed the sales growth to the strong performance of its healthcare IT activities, favorable currency effects, and its recently acquired Heartlab operations. IT sales grew 29% in the quarter, which more than compensated for the continuing decline in North American film and print markets, according to the vendor.
Worldwide PACS orders were exceptionally strong during the first quarter, partly driven by U.S. imaging centers and community-based hospitals, Agfa said. More than 100 sites around the world have signed up for Agfa's Impax 6.0 platform in the six months since its release, according to the vendor.
By AuntMinnie.com staff writers
May 17, 2006
Related Reading
Agfa lands Novation deal, May 15, 2006
MRS, Agfa partner, May 1, 2006
Agfa launches new PACS financing programs, April 28, 2006
Agfa places Impax RIS suite in Kansas clinic, April 27, 2006
Agfa adds Orbis pilot sites in Belgium, March 20, 2006
Copyright © 2006 AuntMinnie.com
